Atiprimod blocks STAT3 phosphorylation and induces apoptosis in multiple myeloma cells

Multiple myeloma (MM) accounts for 1 % of all cancer deaths. Although treated aggressively, almost all myelomas eventually recur and become resistant to treatment. Atiprimod (2-(3-Diethylaminopropyl)-8,8-dipropyl-2-azaspiro[4,5] decane dimaleate) has exerted anti-inflammatory activities and inhibite...

Descripción completa

Detalles Bibliográficos
Autores principales: Amit-Vazina, M, Shishodia, S, Harris, D, Van, Q, Wang, M, Weber, D, Alexanian, R, Talpaz, M, Aggarwal, B B, Estrov, Z
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2005
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361492/
https://www.ncbi.nlm.nih.gov/pubmed/15970928
http://dx.doi.org/10.1038/sj.bjc.6602637

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361492/
https://www.ncbi.nlm.nih.gov/pubmed/15970928
http://dx.doi.org/10.1038/sj.bjc.6602637

Ejemplares similares